The CrkL-SH2 domain-phospho-STAT5 complex can translocate to the nucleus where it binds to the promoter region of c-Abl or Bcr-Abl in CML cells [52]. The gene discussed is CRKL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.